Eli Lilly (LLY) vs. Micron Technology (MU)
This page compares Eli Lilly (LLY) with Micron Technology (MU) using performance and risk, profitability, financial strength, growth, dividends, and valuation metrics.
Company Profile
Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Micron Technology (MU) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.
| Symbol | LLY | MU |
|---|---|---|
| Name | Eli Lilly and Company | Micron Technology, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Information Technology |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Semiconductors & Semiconductor Equipment |
| GICS Industry | Pharmaceuticals | Semiconductors & Semiconductor Equipment |
| GICS Sub-Industry | Pharmaceuticals | Semiconductors |
| Market Capitalization | 1,020.76 billion USD | 1,055.43 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | June 1, 1972 | June 1, 1984 |
| Security Type | Common Stock | Common Stock |
Valuation
Price-to-Earnings Ratio (TTM)
Micron Technology (MU) at 44.25 trades in the lower-multiple quartile for Price-to-Earnings Ratio (TTM), while Eli Lilly (LLY) at 40.65 sits around the industry midpoint — MU has a lower trailing earnings multiple relative to peers, though the gap should be read alongside growth and earnings quality.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.65
- Max
- 86.12
- Q3
- 44.09
- Median
- 25.14
- Q1
- 14.77
- Min
- 1.59
MU
Semiconductors & Semiconductor Equipment industry group
44.25
- Max
- 249.03
- Q3
- 128.05
- Median
- 64.96
- Q1
- 44.86
- Min
- 6.63
Price-to-Sales Ratio (TTM)
On Price-to-Sales Ratio (TTM), both Eli Lilly (LLY) at 14.13 and Micron Technology (MU) at 18.16 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
14.13
- Max
- 41.86
- Q3
- 22.86
- Median
- 6.80
- Q1
- 3.35
- Min
- 0.01
MU
Semiconductors & Semiconductor Equipment industry group
18.16
- Max
- 37.59
- Q3
- 20.61
- Median
- 9.67
- Q1
- 4.25
- Min
- 0.01
Price-to-Book Ratio (MRQ)
Both look rich against book: Micron Technology (MU) at 14.57 sits in the upper Price-to-Book Ratio (MRQ) quartile, and Eli Lilly (LLY) at 32.78 prices even higher, above its industry range.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
32.78
- Max
- 12.97
- Q3
- 6.18
- Median
- 3.45
- Q1
- 1.62
- Min
- -4.60
MU
Semiconductors & Semiconductor Equipment industry group
14.57
- Max
- 25.80
- Q3
- 14.33
- Median
- 7.69
- Q1
- 3.77
- Min
- 0.22
Valuation at a Glance
| Symbol | LLY | MU |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 40.65 | 44.25 |
| Price-to-Sales Ratio (TTM) | 14.13 | 18.16 |
| Price-to-Book Ratio (MRQ) | 32.78 | 14.57 |
| Free Cash Flow Yield | 0.90% | 0.27% |
Profitability
Return on Equity (TTM)
Eli Lilly (LLY) leads with Return on Equity (TTM) of 107.46%, above its industry benchmark range, while Micron Technology (MU) at 39.82% also ranks strongly in the top quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
107.46%
- Max
- 100.65%
- Q3
- 3.39%
- Median
- -31.16%
- Q1
- -61.60%
- Min
- -158.89%
MU
Semiconductors & Semiconductor Equipment industry group
39.82%
- Max
- 39.82%
- Q3
- 17.52%
- Median
- 6.57%
- Q1
- -4.94%
- Min
- -35.15%
Net Profit Margin (TTM)
Eli Lilly (LLY) at 34.99% keeps the most of each sales dollar — above its industry’s Net Profit Margin (TTM) range — and Micron Technology (MU) at 41.49% also retains a top-quartile share.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
34.99%
- Max
- 13.81%
- Q3
- 4.07%
- Median
- 0.00%
- Q1
- -3.07%
- Min
- -13.58%
MU
Semiconductors & Semiconductor Equipment industry group
41.49%
- Max
- 57.72%
- Q3
- 20.98%
- Median
- 7.10%
- Q1
- -3.84%
- Min
- -32.92%
Operating Profit Margin (TTM)
Micron Technology (MU) at 67.62% runs the leaner core operation — above its industry’s Operating Profit Margin (TTM) range — and Eli Lilly (LLY) at 49.39% also operates in the top quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
49.39%
- Max
- 100.30%
- Q3
- 4.94%
- Median
- 0.00%
- Q1
- -133.46%
- Min
- -337.81%
MU
Semiconductors & Semiconductor Equipment industry group
67.62%
- Max
- 65.60%
- Q3
- 21.58%
- Median
- 9.68%
- Q1
- -8.51%
- Min
- -46.64%
Profitability at a Glance
| Symbol | LLY | MU |
|---|---|---|
| Return on Equity (TTM) | 107.46% | 39.82% |
| Return on Assets (TTM) | 20.74% | 20.15% |
| Net Profit Margin (TTM) | 34.99% | 41.49% |
| Operating Profit Margin (TTM) | 49.39% | 67.62% |
| Gross Profit Margin (TTM) | 82.83% | 58.44% |
Growth
Revenue Growth
Revenue Growth at a Glance
| Symbol | LLY | MU |
|---|---|---|
| 1-Year Revenue Growth | 44.70% | 48.85% |
| 3-Year Revenue CAGR | 31.69% | 6.71% |
EPS Growth
EPS Growth at a Glance
| Symbol | LLY | MU |
|---|---|---|
| 1-Year EPS Growth | 95.99% | 984.29% |
| 3-Year EPS CAGR | 51.71% | -0.69% |
Financial Strength
Current Ratio (MRQ)
Micron Technology (MU) at 2.90 keeps Current Ratio (MRQ) within its industry mid-range, while Eli Lilly (LLY) at 1.50 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.50
- Max
- 24.81
- Q3
- 11.75
- Median
- 5.47
- Q1
- 2.69
- Min
- 0.23
MU
Semiconductors & Semiconductor Equipment industry group
2.90
- Max
- 11.30
- Q3
- 6.01
- Median
- 3.26
- Q1
- 2.37
- Min
- 0.51
Debt-to-Equity Ratio (MRQ)
Micron Technology (MU) at 0.15 carries Debt-to-Equity Ratio (MRQ) around its industry mid-range, while Eli Lilly (LLY) at 1.39 sits in the higher-leverage quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 1.60
- Q3
- 0.69
- Median
- 0.16
- Q1
- 0.02
- Min
- 0.00
MU
Semiconductors & Semiconductor Equipment industry group
0.15
- Max
- 1.53
- Q3
- 0.64
- Median
- 0.21
- Q1
- 0.04
- Min
- 0.00
Financial Strength at a Glance
| Symbol | LLY | MU |
|---|---|---|
| Current Ratio (MRQ) | 1.50 | 2.90 |
| Debt-to-Equity Ratio (MRQ) | 1.39 | 0.15 |
| Net Debt / EBITDA | 1.05 | -0.10 |
Dividends
Dividend Yield (TTM)
Both Eli Lilly (LLY) at 0.60% and Micron Technology (MU) at 0.06% report Dividend Yield (TTM) near their industry mid-ranges, so neither company stands out strongly from peers on cash yield relative to share price.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.60%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MU
Semiconductors & Semiconductor Equipment industry group
0.06%
- Max
- 1.15%
- Q3
- 0.46%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Micron Technology (MU) at 2.17% maintains Dividend Payout Ratio (TTM) around its industry median — a balanced dividend policy. Eli Lilly (LLY) at 22.13% sits outside the typical mid-range, leaning toward more retention or more distribution than the industry median.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
22.13%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MU
Semiconductors & Semiconductor Equipment industry group
2.17%
- Max
- 41.26%
- Q3
- 19.10%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividends at a Glance
| Symbol | LLY | MU |
|---|---|---|
| Dividend Yield (TTM) | 0.60% | 0.06% |
| Dividend Payout Ratio (TTM) | 22.13% | 2.17% |
Performance & Risk
Micron Technology (MU) has a highly aggressive beta of 2.17, indicating much higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.51 and tends to be less market-sensitive — a wide gap in beta profiles.
Performance & Risk at a Glance
| Symbol | LLY | MU |
|---|---|---|
| 1-Year Return | 50.32% | 776.52% |
| 1-Year Volatility | 38.24% | 68.82% |
| Beta | 0.51 | 2.17 |
| 3-Month Avg. Volume | 3.15M | 49.48M |